Metrics as of 10/13/2026, 06:51 PM (Berlin time), refresh in progress.
Perrigo Company Stock
Perrigo Company plc
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Ireland
- CEO
- Albert A. Manzone
- Employees
- 8,100
- Market cap
- $2.1 B
- IPO
- 17/12/1991
Perrigo Company plc is a healthcare company operating in the drug manufacturers, specialty & generic industry, headquartered in Dublin, Ireland. Founded in 1887, the company provides over-the-counter health and wellness solutions across the United States, Europe, and international markets. The business operates…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Perrigo Company stock: price history
1D
+0.4%
1W
+10.8%
1M
+13.6%
6M
+35.3%
YTD
+11.5%
1Y
-26.8%
2Y
-36.3%
5Y
-66.2%
10Y
-82.0%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~124% stronger price swings than usual
Ask the agents about Perrigo Company
Analyst assessment of Perrigo Company
PRICE TARGET LOW
US$20.00
CONSENSUS
US$36.20
MEDIAN
US$36.00
PRICE TARGET HIGH
US$54.00
0
STRONG BUY
14
BUY
21
HOLD
1
SELL
0
STRONG SELL
36
TOTAL · Hold
As of: 27/02/2026
Perrigo Company stock metrics
P/E
-1.24
P/B
0.86
EV/EBITDA
-4.82
RETURN ON EQUITY
3.0%
NET MARGIN
7.3%
DEBT/EQUITY
1.31
DIVIDEND YIELD
7.5%
AS OF
27/06/2026
Free float & liquidity
FREE FLOAT
99.6%
FLOAT SHARES
137,766,791
AVG. DAILY VOLUME (30D)
2,710,581
Insider transactions (SEC)
Alford Bradley A
Alford Bradley A
Parker Geoffrey M.
Parker Geoffrey M.
Ball David
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Perrigo Company stock
What does Perrigo Company do?
Perrigo Company plc is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Ireland.
The CEO is Albert A. Manzone, the company employs around 8,100 people.
The IPO was on 17/12/1991; the stock trades on NYSE under the ticker PRGO.
What do analysts say about Perrigo Company stock?
36 analysts rate the stock, the consensus is Hold (as of 27/02/2026).
The average price target is US$36.20, ranging from US$20.00 to US$54.00, with a median of US$36.00.
This is an external assessment, not a statement by Market Jury.
When does Perrigo Company report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 124% stronger than usual.
Does Perrigo Company pay a dividend?
Yes. The last dividend was US$0.29 per share, ex-date 28/08/2026, paid on 15/09/2026.
The dividend yield is 7.5% (as of 27/06/2026).
Which stocks are comparable to Perrigo Company?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Perrigo Company stock analyzed?
Clicking "Analyze stock" lets five strategies assess Perrigo Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.